Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes

出版年份 2018 全文链接

标题

作者

关键词

出版物

Volume 134, Issue -, Pages 43-52

出版商

Elsevier BV

发表日期

2018-03-08

DOI

10.1016/j.steroids.2018.02.010

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started